Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3902 versus placebo in hospitalized acute heart failure with worsening renal function
2006-006843-29Phase 3Completed
- Sponsor
- NovaCardia
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) comparing KW-3902 plus standard therapy with Placebo plus standard therapy (2 arms). Primary endpoint: Primary objective endpoint detail. Started Apr 2007; status: completed.
02
Drugs
rolofylline
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2006-006843-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006843-29.